Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2012
11/13/2012CA2435096C Yeast strains autonomously producing steroids
11/13/2012CA2428473C Method for producing pectin hydrolysis products
11/13/2012CA2326692C Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation
11/08/2012WO2012151578A1 Immunoglobulin-like transcript (ilt) receptors as cd8 antagonists
11/08/2012WO2012151279A2 Induction of il-12 using immunotherapy
11/08/2012WO2012151266A1 Methods for handling biological drugs containing living cells
11/08/2012WO2012122618A8 Immunogenic composition for immune system modulation and use thereof, method for treating and preventing diseases, method for inducing cell regeneration and method for restoring immune response
11/08/2012WO2012110968A3 Treatment of fistulizing crohn's disease
11/08/2012WO2012103365A9 Recombinant t cell ligands and antibodies that bind b cells for the treatment of autoimmune diseases
11/08/2012WO2011003018A9 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof
11/08/2012US20120283695 Transdermal drug delivery patch and method of controlling drug release of the same by near-ir
11/08/2012US20120283308 Animal feed composition
11/08/2012US20120283305 Cysteine protease inhibitors
11/08/2012US20120283303 Use of n-aminoimidazole cytoprotective compounds for treating cell death and/or gsk-3 mediated diseases
11/08/2012US20120283277 Inhibitors of bruton's tyrosine kinase
11/08/2012US20120283268 Thiazole and Thiophene Analogues, and Their Use in Treating Autoimmune Diseases and Cancers
11/08/2012US20120283258 Mediators of hedgehog signaling pathways, compositions and uses related hereto
11/08/2012US20120283247 Diazepane acetamide derivatives as selective 11b-hsd1 inhibitors
11/08/2012US20120283239 1H-[1,2,3]TRIAZOLO[4,5-c]PYRIDINE-4-CARBONITRILE DERIVATIVES
11/08/2012US20120283238 Irak inhibitors and uses thereof
11/08/2012US20120283236 Porphyrin Catalysts and Methods of Use Thereof
11/08/2012US20120283229 1,4-benzodiazepine-2,5-diones and related compounds with therapeutic properties
11/08/2012US20120283228 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
11/08/2012US20120283206 Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.
11/08/2012US20120283187 Controlled release composition and method of producing the same
11/08/2012US20120283181 Crystal forms of saxagliptin and processes for preparing same
11/08/2012US20120283169 Pharmaceutical composition, methods for treating and uses thereof
11/08/2012US20120283168 Template-fixed peptidomimetics with ccr10 antagonistic activity
11/08/2012US20120282464 Spherical Protein Particles and Methods of Making and Using Them
11/08/2012US20120282350 Performance enhancing compositions and methods of use
11/08/2012US20120282332 Composition and method thereof
11/08/2012US20120282329 MUC1 Based Glycolipopeptide Vaccine with Adjuvant
11/08/2012US20120282296 Methods for improving the design, bioavailability, and efficacy of directed sequence polymer compositions via serum protein-based detection of directed sequence polymer compositions
11/08/2012US20120282295 Purification of staphylococcus aureus type 5 and type 8 capsular saccharides
11/08/2012US20120282294 Refrigerator-temperature stable influenza vaccine compositions
11/08/2012US20120282293 Multivalent Live Vector Vaccine against Clostridium difficile-Associated Disease
11/08/2012US20120282292 Methods and compositions related to immunogenic fibrils
11/08/2012US20120282290 Mycobacterial Vaccines
11/08/2012US20120282287 Novel Flavivirus Antigens
11/08/2012US20120282285 Masp isoforms as inhibitors of complement activation
11/08/2012US20120282284 Methods and compositions for producing antigenic responses
11/08/2012US20120282281 Agents that Engage Antigen-Presenting Cells Through Dendritic Cell Asialoglycoprotein Receptor (DC-ASGPR)
11/08/2012US20120282274 Targeting of the c-terminal segment of c.difficile toxin b for improved clinical diagnosis, prevention, and treatment
11/08/2012US20120282270 Formulation of human antibodies for treating tnf-alpha associated disorders
11/08/2012US20120282269 Anti-IL-23 Antibodies
11/08/2012US20120282265 Medicament and a method for regulation of the vascular tone
11/08/2012US20120282254 Cd127 binding proteins
11/08/2012US20120282250 Il-21 antagonists
11/08/2012US20120282246 Compositions and methods for antibody and ligand identification
11/08/2012US20120282223 Amorphous (5-Fluoro-2-methyl-3-quinolin-2-ylmethyl-indol-1-yl)-Acetic Acid
11/08/2012US20120282218 Pyridinone hydroxycyclopentyl carboxamides: hiv integrase inhibitors with therapeutic applications
11/08/2012US20120282216 Composition and Method for Treating Cancer
11/08/2012US20120282215 Vaccination of Cancer Patients
11/08/2012US20120282189 Improved Medicinal Aerosol Formulations
11/08/2012US20120282170 Anti- tnf antibodies, compositions, methods and uses
11/08/2012CA2838046A1 Induction of il-12 using immunotherapy
11/08/2012CA2838041A1 Methods for handling biological drugs containing living cells
11/08/2012CA2834928A1 Compounds for inflammation and immune-related uses
11/08/2012CA2833931A1 Complement factor b analogs and their uses
11/08/2012CA2833324A1 A composition for treating autoimmune disorders and methods thereof
11/07/2012EP2520648A1 Anti-iga1 antibody
11/07/2012EP2519544A1 Polypeptide heterodimers and uses thereof
11/07/2012EP2519543A1 Heterodimer binding proteins and uses thereof
11/07/2012EP2519541A1 Ron binding constructs and methods of use thereof
11/07/2012EP2519257A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens
11/07/2012EP2519250A1 Interferon analogs
11/07/2012EP2213737B1 Double-stranded oligonucleotides
11/07/2012CN1871240B Pyrrolopyrimidine thion derivatives
11/07/2012CN1832929B 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
11/07/2012CN102770452A An IgY for a PA-MSHA bacterial strain, and preparation method and application thereof
11/07/2012CN102770159A Use of ep4 receptor antagonists in the treatment of il-23 mediated diseases
11/07/2012CN102770145A Specialized medical nutrition for surgical and trauma patients containing probiotics
11/07/2012CN102766605A Use of recombinant parainfluenza viruses (PIVs) as vectors to protect against infection and disease caused by PIV and other human pathogens
11/07/2012CN102766596A Novel regulatory T cells and uses thereof
11/07/2012CN102766210A Human CTLA-4 antibodies and their uses
11/07/2012CN102764437A Methoxsalen injection and preparation method thereof
11/07/2012CN102764436A Treatment of TNF alpha related disorders
11/07/2012CN102764434A Preparation method of animal immunopotentiator and application thereof
11/07/2012CN102764429A Composition used for increasing regulatory T cells in vivo and use thereof
11/07/2012CN102764425A Peptide selection method
11/07/2012CN102764424A Drug composition of thymopentin composed of five kinds of amino acids and preparation method thereof
11/07/2012CN102764327A Method for extracting lemon bioflavonoids
11/07/2012CN102764324A Medicine composition for treating neoplastic diseases and improving immunity
11/07/2012CN102764323A Method for preparing medicine composition for treating neoplastic diseases and improving immunity
11/07/2012CN102764318A Traditional Chinese medicine composite for curing chronic and intractable urticaria
11/07/2012CN102764277A Suction therapy for repairing brain cells, containing cerebral hemorrhage and enhancing immune system
11/07/2012CN102764274A Method for extracting propolis
11/07/2012CN102764272A Application of PD-L1 gene modified bone marrow mesenchymal stem cells in graft rejection
11/07/2012CN102764230A Nasal gel or ointment preparation for preventing and/or treating aspiration allergy
11/07/2012CN102764217A Functional skin care product containing purslane extractive and preparation method thereof
11/07/2012CN102327279B Triptolide and lonicerin compatible medicine composition, preparation and application thereof
11/07/2012CN102293813B Application of astragalus-containing medicinal composition to preparation of medicines for treating allergic purpura
11/07/2012CN101991633B Method for extracting tripterygium glycosides, and product and inclusion compound and medicinal composition thereof
11/07/2012CN101980705B Use of benzophenone derivative or salt thereof and TNF alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor
11/07/2012CN101953936B Traditional Chinese medicine preparation for treating immune thrombocytopenia and preparation method thereof
11/07/2012CN101891817B Monoclonal antibody capable of preventing high mobility group box-1 (HMGB-1) and application thereof
11/07/2012CN101891814B Anti-osteopontin OPN monoclonal antibody and application thereof
11/07/2012CN101810674B Chinese medicinal composition for enhancing immunity, and preparation method thereof
11/07/2012CN101652355B N- hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 1172